Owens & Minor (OMI) Set to Announce Quarterly Earnings on Monday

Owens & Minor (NYSE:OMI) is set to post its quarterly earnings results before the market opens on Monday, November 4th. Analysts expect Owens & Minor to post earnings of $0.40 per share for the quarter. Owens & Minor has set its FY24 guidance at $1.40-1.70 EPS.Investors that are interested in participating in the company’s conference call can do so using this link.

Owens & Minor (NYSE:OMI) last issued its quarterly earnings results on Friday, August 2nd. The company reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.33 by $0.03. The company had revenue of $2.67 billion for the quarter, compared to analyst estimates of $2.65 billion. Owens & Minor had a negative net margin of 0.40% and a positive return on equity of 14.66%. Owens & Minor’s revenue was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.18 earnings per share. On average, analysts expect Owens & Minor to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Owens & Minor Stock Performance

NYSE OMI opened at $13.41 on Monday. The company has a market capitalization of $1.03 billion, a price-to-earnings ratio of -26.29, a PEG ratio of 0.43 and a beta of 0.39. Owens & Minor has a twelve month low of $12.36 and a twelve month high of $28.35. The stock has a fifty day simple moving average of $14.90 and a 200 day simple moving average of $16.70. The company has a quick ratio of 0.51, a current ratio of 1.09 and a debt-to-equity ratio of 2.17.

Analyst Ratings Changes

A number of equities analysts recently commented on OMI shares. StockNews.com lowered Owens & Minor from a “buy” rating to a “hold” rating in a research note on Monday, August 26th. Citigroup upgraded shares of Owens & Minor from a “neutral” rating to a “buy” rating and decreased their price objective for the stock from $24.00 to $19.00 in a research report on Friday, July 19th. JPMorgan Chase & Co. dropped their target price on shares of Owens & Minor from $22.00 to $18.00 and set an “underweight” rating on the stock in a report on Wednesday, August 21st. Barclays lowered their price objective on Owens & Minor from $23.00 to $18.00 and set an “equal weight” rating for the company in a research report on Monday, August 5th. Finally, Robert W. Baird cut their target price on Owens & Minor from $20.00 to $19.00 and set a “neutral” rating on the stock in a research report on Tuesday, July 16th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, Owens & Minor presently has a consensus rating of “Hold” and an average target price of $20.00.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.